Cargando…
The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling
Glucagon-like peptide-1 (7–36)amide (GLP-1) plays a central role in regulating blood sugar levels and its receptor, GLP-1R, is a target for anti-diabetic agents such as the peptide agonist drugs exenatide and liraglutide. In order to understand the molecular nature of the peptide–receptor interactio...
Autores principales: | Dods, Rachel L., Donnelly, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718506/ https://www.ncbi.nlm.nih.gov/pubmed/26598711 http://dx.doi.org/10.1042/BSR20150253 |
Ejemplares similares
-
Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
por: Saraiva, Francisco Kerr, et al.
Publicado: (2014) -
Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in
Hypoglycemia
por: Ja’arah, Daria, et al.
Publicado: (2021) -
Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor
por: Helmstädter, Johanna, et al.
Publicado: (2021) -
Glucagon-like peptide 1 (GLP-1)
por: Müller, T.D., et al.
Publicado: (2019) -
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
por: Unger, Jeffrey R., et al.
Publicado: (2011)